{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:43:38Z","timestamp":1774493018474,"version":"3.50.1"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS development and to improve treatment results. The aim of this study was to analyze novel endothelium-biomarkers for PTS in patients with DVT out of the acute phase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A case\u2013control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3\u200amonths. Villalta score was performed at the time of inclusion and used to diagnose and classify the severity of PTS. Plasma inter-cellular adhesion molecule 1 (ICAM-1), P-selectin, fractalkine and vascular endothelial growth factor (VEGF) were quantified using cytometric bead array. Endothelial progenitor cells (EPCs) and circulating endothelial cells (CEC) level were quantified by flow cytometry.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56\/\u03bcl (0.34\u20131.5) vs. 0.20\/\u03bcl (0.11\u20130.77); <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.04) and EPC (0.75\/\u03bcl (0.38\u20131.52) vs. 0.09\/\u03bcl (0.05\u20130.82); <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.0021) compared to no PTS patients. Patients with PTS had significantly higher levels of fractalkine (387.60\u200apg\/ml (222.30\u2013597.90) vs. 98.00\u200apg\/ml (82.30\u2013193.02); <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.044) than patients without PTS. Fracktalkine levels showed a strong linear correlation with Villalta score, <jats:italic toggle=\"yes\">r<\/jats:italic>\u200a=\u200a0.86, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.0001. No differences were observed in P-selectin, ICAM-1 and VEGF between studied groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The formation and early resolution of DVT are characterized by inflammation and endothelial\/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the development of PTS. These results suggest a possible role of these mediators in the maintenance and worsening of PTS turning them into potential therapeutic targets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mbc.0000000000001192","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T09:00:09Z","timestamp":1680685209000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Endothelium-biomarkers for postthrombotic syndrome: a case\u2013control study"],"prefix":"10.1097","volume":"34","author":[{"given":"Sabrina","family":"Ranero","sequence":"first","affiliation":[{"name":"Catedra de Hematologia. Hospital de Clinicas. Facultad de Medicina"},{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Silveira","sequence":"additional","affiliation":[{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"},{"name":"Cl\u00ednica Medica 1. Hospital Maciel, Facultad de Medicina, Universidad de la Republica. Montevideo, Uruguay"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Trias","sequence":"additional","affiliation":[{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreina","family":"Brugnini","sequence":"additional","affiliation":[{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Lens","sequence":"additional","affiliation":[{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Guillermo","sequence":"additional","affiliation":[{"name":"Catedra de Hematologia. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Grille","sequence":"additional","affiliation":[{"name":"Catedra de Hematologia. Hospital de Clinicas. Facultad de Medicina"},{"name":"Laboratorio de Citometria y Biolog\u00eda Molecular. Departamento Basico de Medicina. Hospital de Clinicas. Facultad de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"R1-20250617","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","article-title":"Definition of postthrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization","volume":"7","author":"Kahn","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R2-20250617","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1160\/TH17-08-0598","article-title":"Predictors of post-thrombotic ulcer after acute DVT: the RIETE Registry","volume":"118","author":"Galanaud","year":"2018","journal-title":"Thromb Haemost"},{"key":"R3-20250617","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/jth.14728","article-title":"Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: the CACTUS-PTS study","volume":"18","author":"Galanaud","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R4-20250617","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","article-title":"The postthrombotic syndrome","volume":"2016","author":"Kahn","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"R5-20250617","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2009.07601.x","article-title":"Postthrombotic syndrome: prevalence, prognostication and need for progress","volume":"145","author":"Prandoni","year":"2009","journal-title":"Br J Haematol"},{"key":"R6-20250617","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH10-03-0183","article-title":"The vessel wall: a forgotten player in post thrombotic syndrome","volume":"104","author":"DeRoo","year":"2010","journal-title":"Thromb Haemost"},{"key":"R7-20250617","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jth.13569","article-title":"The postthrombotic syndrome: current evidence and future challenges","volume":"15","author":"Rabinovich","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R8-20250617","first-page":"3527","article-title":"Endothelial cells in physiology and in the pathophysiology of vascular disorders","volume":"91","author":"Cines","year":"1998","journal-title":"Blood"},{"key":"R9-20250617","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1538-7836.2005.01328.x","article-title":"Spatial and temporal dynamics of the endothelium","volume":"3","author":"Aird","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R10-20250617","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/sctm.16-0360","article-title":"Endothelial progenitors: a consensus statement on nomenclature","volume":"6","author":"Medina","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"R11-20250617","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/pr.2017.231","article-title":"Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair","volume":"83","author":"Banno","year":"2018","journal-title":"Pediatr Res"},{"key":"R12-20250617","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/stem.745","article-title":"Concise review: circulating endothelial progenitor cells for vascular medicine","volume":"29","author":"Asahara","year":"2011","journal-title":"Stem Cells"},{"key":"R13-20250617","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2015.07.007","article-title":"Endothelial progenitor cells accelerate the resolution of deep vein thrombosis","volume":"83","author":"Li","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"R14-20250617","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.104.492678","article-title":"Endothelial progenitor cells are recruited into resolving venous thrombi","volume":"111","author":"Modarai","year":"2005","journal-title":"Circulation"},{"key":"R15-20250617","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.7150\/ijms.6887","article-title":"Circulating progenitor and mature endothelial cells in deep vein thrombosis","volume":"10","author":"Alessio","year":"2013","journal-title":"Int J Med Sci"},{"key":"R16-20250617","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/ATVBAHA.108.162289","article-title":"Mechanisms of venous thrombosis and resolution","volume":"28","author":"Wakefield","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R17-20250617","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1471-4906(01)02051-8","article-title":"Fractalkine and vascular injury","volume":"22","author":"Umehara","year":"2001","journal-title":"Trends Immunol"},{"key":"R18-20250617","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R19-20250617","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.03.003","article-title":"Postthrombotic syndrome: short- and long-term incidence and risk factors","volume":"177","author":"Ende-Verhaar","year":"2019","journal-title":"Thromb Res"},{"key":"R20-20250617","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3389\/fimmu.2019.01348","article-title":"Fibrinolysis and inflammation in venous thrombus resolution","volume":"10","author":"Mukhopadhyay","year":"2019","journal-title":"Front Immunol"},{"key":"R21-20250617","doi-asserted-by":"crossref","first-page":"864735","DOI":"10.3389\/fcvm.2022.864735","article-title":"Endothelial cell phenotype, a major determinant of venous thrombo-inflammation","volume":"9","author":"Pilard","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R22-20250617","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1160\/TH04-09-0578","article-title":"Circulating endothelial cells. Biomarker of vascular disease","volume":"93","author":"Blann","year":"2005","journal-title":"Thromb Haemost"},{"key":"R23-20250617","doi-asserted-by":"crossref","first-page":"8270498","DOI":"10.1155\/2017\/8270498","article-title":"Review article progenitor cells for arterial repair: incremental advancements towards therapeutic reality","volume":"2017","author":"Simard","year":"2017","journal-title":"Stem Cells Int"},{"key":"R24-20250617","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.7150\/ijms.6887","article-title":"Circulating progenitor and mature endothelial cells in deep vein thrombosis","volume":"10","author":"Alessio","year":"2013","journal-title":"Int J Med Sci"},{"key":"R25-20250617","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.pharep.2015.05.017","article-title":"The real face of endothelial progenitor cells \u2212 circulating angiogenic cells as endothelial prognostic marker?","volume":"67","author":"Kachamakova-Trojanowska","year":"2015","journal-title":"Pharmacol Rep"},{"key":"R26-20250617","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/cells11101678","article-title":"Endothelial progenitor cells as biomarkers of cardiovascular pathologies: a narrative review","volume":"11","author":"Heinisch","year":"2022","journal-title":"Cells"},{"key":"R27-20250617","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.3390\/ijms222312874","article-title":"Endothelial progenitor cells: an appraisal of relevant data from bench to bedside","volume":"22","author":"Morrone","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R28-20250617","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.thromres.2011.12.011","article-title":"Endothelial progenitor cells and thrombosis","volume":"129","author":"Nuzzolo","year":"2012","journal-title":"Thromb Res"},{"key":"R29-20250617","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2015.11.005","article-title":"Endothelial colony-forming cells: Biological and functional abnormalities in patients with recurrent, unprovoked venous thromboembolic disease","volume":"137","author":"Alvarado-Moreno","year":"2016","journal-title":"Thromb Res"},{"key":"R30-20250617","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711110102","article-title":"The vascularisation of deep-vein thrombi and their fibrous residue: a post mortem angio-graphic study","volume":"111","author":"Sevitt","year":"1973","journal-title":"J Pathol"},{"key":"R31-20250617","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1160\/TH04-09-0596","article-title":"The role of neovascularisation in the resolution of venous thrombus","volume":"93","author":"Modarai","year":"2005","journal-title":"Thromb Haemost"},{"key":"R32-20250617","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.RES.0000137877.89448.78","article-title":"Endothelial progenitor cells: characterization and role in vascular biology","volume":"95","author":"Urbich","year":"2004","journal-title":"Circ Res"},{"key":"R33-20250617","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/stcltm\/szac010","article-title":"Endothelial progenitor cells in coronary artery disease: from bench to bedside","volume":"11","author":"Pelliccia","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"R34-20250617","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"R35-20250617","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5966\/sctm.2015-0227","article-title":"Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges","volume":"5","author":"Chong","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"R37-20250617","first-page":"471","article-title":"Transplantation of VEGF165-gene-transfected endothelial progenitor cells in the treatment of chronic venous thrombosis in rats","volume":"123","author":"Meng","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"R38-20250617","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2015.11.025","article-title":"Transplantation of VEGFl65-overexpressing vascular endothelial progenitor cells relieves endothelial injury after deep vein thrombectomy","author":"Tang","year":"2016","journal-title":"Thromb Res"},{"key":"R39-20250617","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1160\/TH08-07-0453","article-title":"Cell-based therapy facilitates venous thrombus resolution","volume":"101","author":"Santo","year":"2009","journal-title":"Thromb Haemost"},{"key":"R40-20250617","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fmed.2018.00354","article-title":"Recent advances in endothelial progenitor cells toward their use in clinical translation","volume":"0","author":"Keighron","year":"2018","journal-title":"Front Med"},{"key":"R41-20250617","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jca.21967","article-title":"Mobilized and apheresis-collected endothelial progenitor cells with plerixafor","volume":"37","author":"Perdomo","year":"2022","journal-title":"J Clin Apher"},{"key":"R42-20250617","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1538-7836.2009.03286.x","article-title":"Inflammation in deep vein thrombosis and the development of postthrombotic syndrome: a prospective study","volume":"7","author":"Roumen-Klappe","year":"2009","journal-title":"J Thromb Haemost"},{"key":"R43-20250617","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0300985812469883","article-title":"Getting leukocytes to the site of inflammation","volume":"50","author":"Muller","year":"2013","journal-title":"Vet Pathol"},{"key":"R44-20250617","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.thromres.2015.03.020","article-title":"Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability","volume":"135","author":"Zhang","year":"2015","journal-title":"Thromb Res"},{"key":"R45-20250617","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2015.05.019","article-title":"Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques","volume":"241","author":"Edsfeldt","year":"2015","journal-title":"Atherosclerosis"},{"key":"R46-20250617","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0038-1629897","article-title":"CX 3\u200aCR1\/CX 3 CL1 axis mediates platelet-leukocyte adhesion to arterial endothelium in younger patients with a history of idiopathic deep vein thrombosis","volume":"118","author":"Furio","year":"2018","journal-title":"Thromb Haemost"},{"key":"R47-20250617","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.thromres.2015.06.024","article-title":"Predictive value of markers of inflammation in the postthrombotic syndrome: a systematic review: inflammatory biomarkers and PTS","volume":"136","author":"Rabinovich","year":"2015","journal-title":"Thromb Res"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:08:57Z","timestamp":1750201737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0000000000001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0000000000001192","relation":{},"ISSN":["0957-5235","1473-5733"],"issn-type":[{"value":"0957-5235","type":"print"},{"value":"1473-5733","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}